Fabrice Balavoine
Chief Tech/Sci/R&D Officer bij QUANTUM GENOMICS
Profiel
Fabrice Balavoine is currently the Director of Research & Development at Quantum Genomics SA and a Project Manager at Harvard Medical School.
He previously worked as a Manager of Research & Development at Quantum Genomics Corp.
and as a Vice President of Chemistry at Sepal Pharma SA. Balavoine holds a doctorate from Université de Paris XI Paris Sud, an MBA from ESSEC Business School, and a graduate degree from École Supérieure de Physique et de Chimie de Paris.
Actieve functies van Fabrice Balavoine
| Bedrijven | Functie | Begin |
|---|---|---|
| QUANTUM GENOMICS | Chief Tech/Sci/R&D Officer | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Eerdere bekende functies van Fabrice Balavoine
| Bedrijven | Functie | Einde |
|---|---|---|
Quantum Genomics Corp.
 Quantum Genomics Corp. Pharmaceuticals: OtherHealth Technology Quantum Genomics Corp. operates as a global biotechnology company. It researches and develops treaments for human diseases, including cardiovascular diseases, neurology and metabolic related diseases. The company is headquartered in Jersey City, NJ. | Chief Tech/Sci/R&D Officer | - |
Sepal Pharma SA
 Sepal Pharma SA Pharmaceuticals: MajorHealth Technology Sepal Pharma SA develops cancer therapies. The company was founded on July 20, 2004 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Opleiding van Fabrice Balavoine
| ESSEC Business School | Masters Business Admin |
| École Supérieure de Physique et de Chimie de Paris | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| QUANTUM GENOMICS | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Quantum Genomics Corp.
Quantum Genomics Corp. Pharmaceuticals: OtherHealth Technology Quantum Genomics Corp. operates as a global biotechnology company. It researches and develops treaments for human diseases, including cardiovascular diseases, neurology and metabolic related diseases. The company is headquartered in Jersey City, NJ. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
Sepal Pharma SA
Sepal Pharma SA Pharmaceuticals: MajorHealth Technology Sepal Pharma SA develops cancer therapies. The company was founded on July 20, 2004 and is headquartered in Paris, France. | Health Technology |
